Local Health Department Naloxone Grant (IN)

The Indiana Department of Health is inviting local health departments to apply for the Naloxone Grant to distribute opioid overdose reversal kits, including naloxone nasal spray. This initiative aims to increase the availability of life-saving medication in communities, especially in collaboration with organizations such as county jails. Education on the use of naloxone and legal protections for responders is also a key component of the program, fostering a safer environment for overdose interventions.

NOTE: Applicants are encouraged to apply at their earliest convenience. Overdose reversal kits will be awarded on an ongoing basis.
Purpose
The Indiana Department of Health is accepting applications from local health departments (LHDs) in response to the grant opportunity for the distribution of opioid overdose reversal kits that include naloxone nasal spray. IDOH will be responsible for awarding the number of overdose reversal kits and is partnering with Overdose Lifeline to distribute the kits to LHDs. LHDs will be responsible for the distribution of kits in their communities.
Naloxone hydrochloride is an opioid antagonist and a safe and effective medication used to quickly reverse the life-threatening effects of an opioid overdose. The naloxone kits distributed in accordance with this grant will be administered intranasally by spraying a fine mist up the nostril of the affected person.
The goal of this grant is to expand the number of LHDs that participate in the distribution of opioid overdose reversal kits. LHDs are highly encouraged to collaborate with community organizations, including county jails, for this opportunity. Jails in the county will be able to receive naloxone kits through the LHD to give to incarcerated persons upon their release.
This effort will require providing education about naloxone kit programs and the law that provides immunity for lay responders to carry and administer the life-saving medication. Lay responders who agree to participate in a naloxone kit program must be trained by the awardee on how to administer naloxone (if not previously trained).